Medscape

Collagenase Ointment Application at 24- Versus 48-Hour Intervals in the Treatment of Pressure Ulcers: A Randomized Multicenter Study

The recommended use of collagenase ointment consists of daily application of a 1 to 2mm thick layer on the ulcer bed (according to the manufacturers). Daily care of chronic ulcers in hospitalised or ...
The New York Times

McAllister's All-Healing Ointment.; APPLICATION FOR AN INJUCTION REFUSED.

TimesMachine is an exclusive benefit for home delivery and digital subscribers. About the Archive This is a digitized version of an article from The Times’s print archive, before the start of online ...
Healthline

All About Nystatin Topical Forms

If you have a fungal skin infection, your doctor may prescribe a topical form of nystatin for you. (A topical drug is applied to the skin.) Nystatin is an antifungal drug used in adults and children ...
Nature

Can Nitroglycerine Ointment Facilitate Newborn Heelstick Blood Collection? A Randomized Controlled Trial

Newborn heelstick blood collection can be a painful procedure in part because of the time required to obtain sufficient quantity of blood. No previous studies have determined whether local ...
BMJ

Topical glyceryl trinitrate (GTN) and eccentric exercises in the treatment of mid-portion achilles tendinopathy (the NEAT trial): a randomised double-blind placebo-controlled trial

Objectives To investigate if daily treatment with glyceryl trinitrate (GTN) ointment, over 24 weeks combined with a 12-week eccentric exercise programme is more effective for chronic mid-portion ...
Business Wire

Anacor Pharmaceuticals Submits New Drug Application to the FDA for Crisaborole Topical Ointment, 2% for the Treatment of Mild-to-Moderate Atopic Dermatitis

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking ...
Nasdaq

U.S. FDA Approves Supplemental New Drug Application (sNDA) for Expanded Indication of EUCRISA® (Crisaborole) Ointment, 2%, in Children as Young as 3 Months of Age With Mild-to ...

EUCRISA is the first and only 100% steroid-free, topical prescription medication approved for patients as young as 3 months of age in the United States AD is a chronic skin disease characterized by ...